Tag: Medtronic

First patient treated in TERMINATE AF clinical trial

The first patient has been treated in the TERMINATE AF trial (Medtronic). This is a multi-centre study evaluating two surgical ablation devices—the Cardioblate irrigated...

Medtronic disables internet updates in CareLink CIEDs due to cybersecurity risks

Medtronic has issued a software update "to address a safety risk caused by cybersecurity vulnerabilities" in 34,000 of their cardiac implantable electronic devices (CIEDs),...

Study shows improved quality of life and reduced symptoms in patients...

New findings from the CRYO4PERSISTENT AF clinical trial demonstrate improved quality of life, reduced symptoms from abnormal heart rhythms, and low incidence of reinterventions...

Clinical trial to evaluate ECG belt for optimising heart failure therapy...

Medtronic has announced the first enrolments in a new clinical trial evaluating the ECG (electrocardiography) Belt Research System (ECG Belt) as a diagnostic tool...

Expanded indication for pacing lead for His bundle site stimulation

A press release has announced US Food and Drug Administration (FDA) labeling expansion for the Medtronic SelectSecure MRI SureScan Model 3830 cardiac pacing lead...

FDA classifies HeartWare HVAD systems unexpected power source switching as Class...

The United States Food and Drug Administration (FDA) has classified Medtronic recent voluntary urgent field action related to the HeartWare HVAD System unexpected power...

Study confirms feasibility of new extravascular approach to ICD therapy

Results from a research study demonstrating the feasibility of a novel approach to delivering pacing and defibrillation therapy in which a lead is placed...

Medtronic: class I recall- manufacturing error preventing electrical shock delivery

Medtronic is recalling certain implantable cardioverter defibrillators (ICDs) and cardiac resynchronisation therapy defibrillators (CRT-Ds) due to a defect in the manufacturing process.  This defect...

Medtronic HeartWare HVAD approved for destination therapy

The US Food and Drug Administration (FDA) has approved Medtronic’s HeartWare HVAD system as a destination therapy for patients with advanced heart failure who...

CE mark granted to Medtronic for Attain Stability Quad MRI SureScan...

Medtronic has received CE mark for the Attain Stability Quad MRI SureScan left heart lead. The device offers active-fixation technology, designed for precise lead...

First patients enrolled in Medtronic’s STOP AF First cryoballoon clinical trial

The first participants have been enrolled in Medtronic’s STOP AF First clinical trial. The trial will evaluate the safety and effectiveness of performing pulmonary...

Improved therapy and reduced healthcare costs demonstrated for Medtronic CRT devices

New data showing the use of Medtronic’s cardiac resynchronisation therapy (CRT) devices—with its proprietary AdaptivCRT and EffectiveCRT algorithms—to result in lower healthcare system costs...

Medtronic Reactive ATP therapy slows atrial fibrillation progression in real-world population

Medtronic has announced that its Reactive atrial-based antitachycardia pacing (ATP) therapy slows the progression of atrial fibrillation (AF) in patients with implanted cardiac devices....

Data reinforce benefits of Medtronic cardiac resynchronisation therapy technologies in ‘real-world’...

New data supporting the clinical performance of the company's exclusive EffectivCRT diagnostic and AdaptivCRT algorithm in heart failure patients who receive cardiac resynchronisation therapy...

HRS 2017: True incidence of atrial fibrillation is underestimated

A substantial number of patients at risk for atrial fibrillation (AF) may remain undetected using conventional monitoring techniques, a late-breaking clinical trial session at...

Medtronic receives FDA approval for MR-conditional quadripolar CRT pacemakers

Medtronic has received US Food and Drug Administration (FDA) approval for a portfolio of quadripolar cardiac resynchronization therapy-pacemakers (CRT-Ps) that are designed to improve...

Medtronic ENDURANCE Supplemental trial of HVAD fails to meet primary endpoint

Medtronic’s ENDURANCE Supplemental trial of the company’s HVAD ventricular assist device has failed to meet its primary endpoint of all neurological events at 12...

Medtronic initiates global trial of Arctic Front Advance cardiac cryoablation catheter

Medtronic has enrolled the first participants in the STOP Persistent AF clinical trial. The trial will evaluate the safety and effectiveness of a pulmonary...

US FDA approves expanded indication for Medtronic Freezor Xtra cryoablation catheter

The US Food and Drug Administration (FDA) has approved Medtronic’s Freezor Xtra cryoablation catheter for treating patients with atrioventricular nodal re-entrant tachycardia (AVNRT). The...

Advancements in Persistent AF Ablation: New Clinical Evidence and Techniques

This webinar has been sponsored by Medtronic.  Watch the recent webinar on persistent Atrial Fibrillation (AF) ablation with Prof. Schilling (St. Barts, London), Prof. de...

US FDA clears CardioInsight noninvasive 3D mapping system

Medtronic has received US Food and Drug Administration (FDA) 510(k) clearance for the CardioInsight noninvasive 3D mapping system. The CardioInsight system is used to...

Discover the latest evidence and ablation techniques for persistent AF treatment

Join atrial fibrillation (AF) experts Prof Richard Schilling (St Barts Hospital, London UK), Prof Carlo de Asmundis (Universitair Ziekenhuis, Brussels, Belgium) and PD Dr...

Medtronic receives CE mark for less-invasive HVAD implant procedure

Medtronic’s HVAD system left ventricular assist device (LVAD) has received CE mark for a less-invasive implant procedure in patients with advanced heart failure. The...

US FDA approves Medtronic’s Claria MRI Quad cardiac resynchronisation therapy defibrillator

Medtronic has received US Food and Drug Administration (FDA) approval for the Claria MRI Quad cardiac resynchronisation therapy defibrillator (CRT-D) SureScan device for patients...

Medtronic gets FDA approval for MRI compatible cardiac rhythm and heart...

Medtronic has announced US Food and Drug Administration (FDA) approval for its suite of cardiac rhythm and heart failure devices and leads to be...

ESC 2016 Clinical Practice Guidelines describe benefits of cryoballoon ablation and...

Cryoballoon ablation for patients with diagnosed atrial fibrillation, and long-term cardiac monitoring for survivors of stroke who do not have an established diagnosis of atrial...

New alliance for heart failure calls for improved care for condition

A coalition of charities, patient groups, professional bodies and healthcare companies with an interest in heart failure has been established to raise the profile...

Medtronic EffectivCRT-during atrial fibrillation algorithm can improve therapy delivery

The Cardiac Resynchronization Therapy Efficacy Enhancement (CRTee) study has shown that the Medtronic EffectivCRT-during atrial fibrillation algorithm can improve therapy delivery in heart failure...

Medtronic Micra TPS sustains low complication rate through 12 months

New long-term results from the Medtronic Micra Transcatheter System Global Clinical Trial have shown consistently low rates of major complication. The data—from largest and...